Johnson & Johnson to buy heart device maker Abiomed in $16.6bn deal

Financial Times | Nov 1, 2022 at 1:24 PM
  • …Johnson & Johnson has agreed to buy cardiovascular technology group Abiomed for $16.6bn, including debt, a sign that mega dealmaking remains robust in the US…